New drug company to investigate novel multiple sclerosis treatments to halt progression of the disease

By Jamie Bell

18 Feb 20

Pheno Therapeutics will investigate new multiple sclerosis treatments using technology and expertise from the University of Edinburgh

PharmaceuticalsContract Manufacturing

Novartis, NHS England to collaborate on cardiovascular diseases

By NS Healthcare Staff Writer

14 Jan 20

The collaboration includes three projects that tackle the CVD challenge and provides enhanced opportunities for life science sector…

Partnerships and Licensing AgreementsPharmaceuticals

CytoDyn, Vyera partner to market leronlimab in US for HIV treatment

By NS Healthcare Staff Writer

18 Dec 19

CytoDyn intends to obtain FDA approval for leronlimab in combination therapy, and file a biologics license application (BLA)…

PharmaceuticalsPartnerships and Licensing Agreements

ViiV Healthcare to develop N6LS for treatment and prevention of HIV

By NS Healthcare Staff Writer

22 Nov 19

bNAbs are the antibodies capable of recognising and blocking the entry of different strains of HIV into healthy…

PharmaceuticalsPartnerships and Licensing Agreements

MedicaSafe, Amneal collaborate on MedicaSafe SmartKey System

By NS Healthcare Staff Writer

04 Oct 19

The MedicaSafe SmartKey records details of each dispensation and transfers data to a cloud portal for prescriber review

PharmaceuticalsDrug Delivery Systems

Ironwood, AstraZeneca revise collaboration agreement for LINZESS in China

By NS Healthcare Staff Writer

19 Sep 19

In January 2019, the National Medical Products Administration has approved the use of LINZESS for adults with IBS-C…

PharmaceuticalsPartnerships and Licensing Agreements

Gilead, Galapagos complete transformative research and development partnership

By NS Healthcare Staff Writer

26 Aug 19

Gilead Sciences is a research-based biopharmaceutical company engaged in discovery, development and commercialisation of medication

PharmaceuticalsDrug discovery